BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28756216)

  • 1. Current controversies in cholangiocarcinoma.
    Hoyos S; Navas MC; Restrepo JC; Botero RC
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1461-1467. PubMed ID: 28756216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cholangiocarcinoma.
    Mertens JC; Ilyas SI; Gores GJ
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1454-1460. PubMed ID: 28844952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.
    Macias RIR; Banales JM; Sangro B; Muntané J; Avila MA; Lozano E; Perugorria MJ; Padillo FJ; Bujanda L; Marin JJG
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1468-1477. PubMed ID: 28782657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma: State of the Art.
    Moazzami B; Majidzadeh-A K; Dooghaie-Moghadam A; Eslami P; Razavi-Khorasani N; Iravani S; Khoshdel A; Shahi F; Dashti H; Mehrvar A; Nassiri Toosi M
    J Gastrointest Cancer; 2020 Sep; 51(3):774-781. PubMed ID: 32157571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoresistance and chemosensitization in cholangiocarcinoma.
    Marin JJG; Lozano E; Herraez E; Asensio M; Di Giacomo S; Romero MR; Briz O; Serrano MA; Efferth T; Macias RIR
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1444-1453. PubMed ID: 28600147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma.
    Khan AS; Dageforde LA
    Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
    Pinto C; Giordano DM; Maroni L; Marzioni M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.
    Cadamuro M; Stecca T; Brivio S; Mariotti V; Fiorotto R; Spirli C; Strazzabosco M; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1435-1443. PubMed ID: 28757170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
    Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
    Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation and management of intrahepatic cholangiocarcinoma.
    Farges O; Fuks D
    Gastroenterol Clin Biol; 2010 Mar; 34(3):191-9. PubMed ID: 20202770
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrahepatic cholangiocarcinoma.
    Poultsides GA; Zhu AX; Choti MA; Pawlik TM
    Surg Clin North Am; 2010 Aug; 90(4):817-37. PubMed ID: 20637950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selection of therapy from the prognosis for stage IV hilar cholangiocarcinoma--extended hepatectomy vs stenting].
    Uchiyama K; Yamaue H
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():555-9. PubMed ID: 16457325
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
    Esnaola NF; Meyer JE; Karachristos A; Maranki JL; Camp ER; Denlinger CS
    Cancer; 2016 May; 122(9):1349-69. PubMed ID: 26799932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma.
    Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostics and treatment of cholangiocellular carcinoma].
    Zender L; Malek NP
    Internist (Berl); 2016 Dec; 57(12):1191-1205. PubMed ID: 27822622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update.
    Khan SA; Davidson BR; Goldin RD; Heaton N; Karani J; Pereira SP; Rosenberg WM; Tait P; Taylor-Robinson SD; Thillainayagam AV; Thomas HC; Wasan H;
    Gut; 2012 Dec; 61(12):1657-69. PubMed ID: 22895392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of surgical management of intrahepatic cholangiocarcinoma.
    Squires MH; Cloyd JM; Dillhoff M; Schmidt C; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):671-681. PubMed ID: 29911912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of peripheral intrahepatic cholangiocarcinoma with distant metastasis.
    Izumi R; Shimizu K; Kiriyama M; Yagi M; Matsui O; Nonomura A; Miyazaki I
    Am J Gastroenterol; 1995 Mar; 90(3):505-7. PubMed ID: 7872300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.